BCL11B Antikörper (N-Term)
Kurzübersicht für BCL11B Antikörper (N-Term) (ABIN347801)
Target
Alle BCL11B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Reacts with human 95 kDa protein
-
Kreuzreaktivität
- Maus
-
Kreuzreaktivität (Details)
- Cross reacts with human BCL11A (91 kDa). May cross react with BCL11B & A from mouse and other species, due to the homology.
-
Aufreinigung
- Antiserum
-
Immunogen
- Synthetic peptide derived from Nter domain of common domain of human BCL-11B and BCL-11A
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IHC : 1/50 to 1/500 - WB : 1/200 to 1/2 000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- BCL11B (B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B))
-
Andere Bezeichnung
- B-Cell Lymphoma/leukemia 11B (BCL-11B)
-
Hintergrund
- Tumor-suppressor protein involved in T-cell lymphomas. May function on the P53-signaling pathway. May be a key regulator of both differentiation and survival during thymocyte development. Repress transcription through direct, TFCOUP2-independent binding to a GC-rich response element
-
UniProt
- Q9C0K0
Target
-